5-aminolevulinic acid (topical) 20%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 5-aminolevulinic acid (topical) 20%, covering 2014-01-31 to 2014-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate [Phase 4]